07/02/2006 (Agence Europe) - The European Commission has authorised the proposal of the Swiss company, Novartis, to acquire the American biotechnology company, Chiron Corporation, which operates in the field of blood tests, biopharmaceutical products and human vaccines. After scrutiny of the matter, the Commission did not find any major overlapping of activities or competition between companies, with the products in question having different methods of application and different therapeutic...